Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

75.0%

3 terminated/withdrawn out of 4 trials

Success Rate

25.0%

-61.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05465655Not ApplicableTerminated

Cara CDRM (Conduction Disturbance Risk Monitor) 2.0

Role: lead

NCT05791344Terminated

Intra-procedural ECG Changes During TAVR

Role: lead

NCT05657912Completed

Cara CDRS (Conduction Disturbance Risk Score) 1.0

Role: lead

NCT05155943Not ApplicableTerminated

K2 Medical KALPA X™ Mapping, Imaging and Navigation Device

Role: lead

All 4 trials loaded